In the competitive field of Pain/inflammation Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Pain/inflammation Drugs technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Pain/inflammation Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Pain/inflammation Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Pain/inflammation Drugs industry

EP3866765Injectable Long-Acting Naltrexone Microparticle CompositionsCHONG KUN DANG PHARMACEUTICAL CORP.Nov 6, 2024ALKERMES PHARMA IRELAND LIMITED
EP3595667Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCES, INC.Sep 20, 2024ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
EP3595667Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCES, INC.Sep 17, 2024BOTTI & FERRARI S.P.A.
EP3862003An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline AnimalsBOEHRINGER INGELHEIM VETMEDICA GMBHJul 24, 2024ELANCO, INC.
EP4142703Compound And Composition For Inducing NeuroprotectionUNIVERSITE DE MONTPELLIERJul 16, 2024BELHADJ-TAHAR HAFID
EP3866615Human Dietary Supplement And Method For Treating Digestive System And Immune-Related DisordersFREEDOM HEALTH, LLCMay 30, 2024N.V. NUTRICIA
EP4028021Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding CompositionsNUVAMID SAMay 30, 2024SCHLICH LTD
EP4084799Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsNUVAMID SAMay 30, 2024SCHLICH LTD
EP4106757Methods Involving Neutrophil Elastase Inhibitor Alvelestat For Treating Respiratory Disease Mediated By Alpha-1 Antitrypsin DeficiencyMEREO BIOPHARMA 4 LIMITEDMay 23, 2024ELKINGTON AND FIFE LLP
EP3090729EmulsionAYANDA GROUP ASMar 6, 2024SIRIO HEALTHCARE (ANHUI) CO., LTD.

To stay ahead in the competitive Pain/inflammation Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Pain/inflammation Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3078667Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES11
EP2397142Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA GMBH & CO. KG5
EP2223688May 29, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE CORPORATION5
EP3241550Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsGRÜNENTHAL GMBH4
EP2797581May 6, 2020Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneCELGENE CORPORATION3
EP3595667Dec 20, 2023Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMA S.P.A.3
EP2214679Mar 27, 2019Corticosteroid CompositionsMERITAGE PHARMA, INC.2
EP2849754Sep 14, 2022A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or SepsisBOEHRINGER INGELHEIM INTERNATIONAL GMBH2
EP2305711Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The SameRINAT NEUROSCIENCE CORP.2
EP2356914Dec 9, 2020Composition For Improving Membrane Composition And Functioning Of CellsN.V. NUTRICIA2